View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Keeping Package Inserts of Drug Products Up to Date

Your drug product labeling (aka package insert) may be out of date for a variety of reasons.

These include many less obvious concerns such as pregnancy categories, outdated references, different labeling in other countries, or safety concerns that have been described by other drugs in the same class.

Many factors can affect the information, which should be included in your drug product’s package insert, and several are described in this paper.

It is the obligation of the sponsor to ensure that drug product labeling is compliant (current, complete, comprehensive, correct, and consistent).

It may be time for a critical review of your drug’s package insert. Feel free to download this paper and contact us to learn more.

Clinical trial consulting and pharmaceutical consulting professionals will benefit by becoming current on adaptive trial design.
Safety surveillance and pharmacovigilance consulting to generic drug manufacturers, as well as generic drug labelling consulting may soon become a service in demand.
Pharmaceutical Development Group (PDG) is a drug and medical device consultant that continuously engages in meetings and interactions with the US Food and Drug Administration...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology